(15313251), S. H. T., (15313254), E. B., (15034119), T. S., (15313257), E. M. K., (14960841), S. W. N., (15313260), M. A., . . . (14960922), A. W. W. (2025). Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer.
Chicago-čujuhus (17. p.)(15313251), Sofie H. Tolmeijer, et al. Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer. 2025.
MLA-čujuhus (9. p.)(15313251), Sofie H. Tolmeijer, et al. Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer. 2025.